Design, conduct, analysis and reporting of a multi-national placebo-controlled trial of activated protein C for persistent septic shock

The role of drotrecogin alfa (activated) (DAA) in severe sepsis remains controversial and clinicians are unsure whether or not to treat their patients with DAA. In response to a request from the European Medicines Agency, Eli Lilly will sponsor a new placebo-controlled trial and history suggests the...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Finfer, Simon, Ranieri, V. Marco, Thompson, B. Taylor, Barie, Philip S., Dhainaut, Jean-François, Douglas, Ivor S., Gårdlund, Bengt, Marshall, John C., Rhodes, Andrew
Médium: Artigo
Jazyk:Inglês
Vydáno: Springer-Verlag 2008
Témata:
Special Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC2995439/
https://ncbi.nlm.nih.gov/pubmed/18839141
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00134-008-1266-6
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky